Pharmacological treatment of hyperglycemia in type 2 diabetes
We update protocols when new clinical trial data publishes (for example, when TRIUMPH Phase 3 readouts update the retatrutide protocol), when regulatory status changes (the February 2026 FDA Category 2 reclassification affected multiple compound pages), or when reconstitution math needs correction
Signs of kidney problems may include changes in urination patterns, swelling in the legs or feet, or unusual fatigue
OZiva Glutathione Builder is a unique combination of herbal extracts and active ingredients for increased glutathione building in the body
These modifications, however minor, legally transform a "copy" into a "custom formulation." "The compounding law is clear," Geoff Cook, CEO of digital health company Noom, which continues prescribing compounded semaglutide, told Axios